riluzole has been researched along with Skin Diseases in 1 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Llorente, X | 1 |
| Esteruelas, G | 1 |
| Bonilla, L | 1 |
| Agudelo, MG | 1 |
| Filgaira, I | 1 |
| Lopez-Ramajo, D | 1 |
| Gong, RC | 1 |
| Soler, C | 1 |
| Espina, M | 1 |
| García, ML | 1 |
| Manils, J | 1 |
| Pujol, M | 1 |
| Sánchez-López, E | 1 |
1 other study available for riluzole and Skin Diseases
| Article | Year |
|---|---|
Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases.
Topics: Drug Carriers; Drug Liberation; Humans; Lipids; Nanoparticles; Nanostructures; Particle Size; Riluzo | 2023 |